A chain built for trading is now betting its future on tokenized everything.
BUSINESS
Injective is a Layer 1 blockchain purpose-built for financial applications, giving developers on-chain modules to build decentralized exchanges, prediction markets, and lending protocols.
Its new whitepaper, released October 9, reframes the project as comprehensive financial infrastructure for tokenization and AI-integrated finance.
On the tokenization front, more than $1B in mortgage records was brought on-chain in September, and the team has filed for an SEC registered transfer agent license to support tokenized stocks and bonds.
Two new launchpads, RunUp and Sprout, launched October 1 and 3 to let projects raise with embedded social trading and perpetual-futures mechanics.
TECHNOLOGY
Injective is built on the Cosmos SDK with Tendermint-based proof of stake, tuned for fast, secure, interoperable transactions.
The network ships an on-chain order book module that any exchange can build on, rather than forcing liquidity into isolated pools.
Cross-chain bridging infrastructure connects to EVM chains like Ethereum and non-EVM chains like Solana.
The core contracts were audited by CertiK, most recently in September 2020.
SECTOR
Injective sits in the Layer 1 and DeFi-infrastructure sector, where 2026 attention has shifted toward tokenization and institutional on-ramps.
As of October 8, three U.S. ETF applications for $INJ are filed and pending approval, from 21Shares, Canary, and REX-Osprey.
A filing is a step, not an approval: whether these products launch and attract inflows is still undetermined.
Competition for tokenized-asset infrastructure is intensifying across the sector, with established L1s racing to court the same institutional demand.
COMPETITION
As a Cosmos SDK chain, Injective shares DNA with $ATOM's ecosystem, though $ATOM is the hub token of the Cosmos network rather than a DeFi-specific chain.
Among general-purpose L1s, $SOL competes for the same developer and liquidity mindshare, pairing higher raw throughput with its own tokenized-asset ambitions.
Injective's pitch against both is specialization: finance-native modules instead of a general-purpose chain.
TOKENOMICS
Per CoinGecko, $INJ carries a market cap and fully diluted valuation of roughly $767M, with 100M tokens circulating against a 100M total supply.
With circulating equal to total, there is no unlock schedule overhang hanging over the price.
The protocol runs a weekly burn auction funded by dApp fees: more than 7.2M INJ has been burned to date, including 25,200 INJ from the September community buyback.
Staking hit an all-time high above 58.8M INJ in early September, about 59% of supply locked on-chain.
Not financial advice. DYOR.
$INJ
